

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.43332734 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.43332734 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.17244063 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.17244063 |
| 5 | serine family amino acid biosynthetic process (GO:0009070) | 4.62517872 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.58658790 |
| 7 | central nervous system myelination (GO:0022010) | 4.57096091 |
| 8 | axon ensheathment in central nervous system (GO:0032291) | 4.57096091 |
| 9 | L-serine metabolic process (GO:0006563) | 4.43941127 |
| 10 | fatty acid elongation (GO:0030497) | 4.39445423 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.36966142 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.24038615 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.17768493 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.17768493 |
| 15 | cysteine metabolic process (GO:0006534) | 4.14381025 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 4.14190372 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.03597101 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.03549308 |
| 19 | response to peptidoglycan (GO:0032494) | 4.02770659 |
| 20 | glycine metabolic process (GO:0006544) | 3.97515071 |
| 21 | serine family amino acid metabolic process (GO:0009069) | 3.93058399 |
| 22 | heme transport (GO:0015886) | 3.91636470 |
| 23 | cellular extravasation (GO:0045123) | 3.90213953 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.89903394 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.89903394 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.89903394 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.89903394 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.89903394 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.89903394 |
| 30 | cholesterol biosynthetic process (GO:0006695) | 3.84780697 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.79406974 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.78485321 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.76966768 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.75323229 |
| 35 | detection of other organism (GO:0098543) | 3.71417455 |
| 36 | glyoxylate metabolic process (GO:0046487) | 3.70046759 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.68865798 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.68828215 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 3.68795491 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.64979719 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58027296 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 3.54257642 |
| 43 | detection of bacterium (GO:0016045) | 3.53579069 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.51530520 |
| 45 | urea metabolic process (GO:0019627) | 3.50726052 |
| 46 | urea cycle (GO:0000050) | 3.50726052 |
| 47 | bile acid biosynthetic process (GO:0006699) | 3.50634695 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.46100737 |
| 49 | phospholipid efflux (GO:0033700) | 3.41483285 |
| 50 | respiratory burst (GO:0045730) | 3.38006985 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 3.37295326 |
| 52 | indolalkylamine catabolic process (GO:0046218) | 3.37295326 |
| 53 | tryptophan catabolic process (GO:0006569) | 3.37295326 |
| 54 | alpha-linolenic acid metabolic process (GO:0036109) | 3.35712263 |
| 55 | negative regulation of interleukin-12 production (GO:0032695) | 3.35123479 |
| 56 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.34356731 |
| 57 | sterol biosynthetic process (GO:0016126) | 3.34241717 |
| 58 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.33945622 |
| 59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.33945622 |
| 60 | nitrogen cycle metabolic process (GO:0071941) | 3.33214113 |
| 61 | regulation of bile acid biosynthetic process (GO:0070857) | 3.30865692 |
| 62 | mannose metabolic process (GO:0006013) | 3.30716523 |
| 63 | folic acid metabolic process (GO:0046655) | 3.27038873 |
| 64 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.26776783 |
| 65 | aromatic amino acid family metabolic process (GO:0009072) | 3.26314907 |
| 66 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.24795170 |
| 67 | kynurenine metabolic process (GO:0070189) | 3.24662023 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.22085578 |
| 69 | intestinal cholesterol absorption (GO:0030299) | 3.21113662 |
| 70 | tryptophan metabolic process (GO:0006568) | 3.20914121 |
| 71 | bile acid metabolic process (GO:0008206) | 3.20584037 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.17851279 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16970264 |
| 74 | B cell mediated immunity (GO:0019724) | 3.15944137 |
| 75 | neutrophil activation (GO:0042119) | 3.15819566 |
| 76 | homocysteine metabolic process (GO:0050667) | 3.15755710 |
| 77 | detection of external biotic stimulus (GO:0098581) | 3.15498244 |
| 78 | positive thymic T cell selection (GO:0045059) | 3.14255392 |
| 79 | detection of molecule of bacterial origin (GO:0032490) | 3.12277699 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 3.11965469 |
| 81 | B cell receptor signaling pathway (GO:0050853) | 3.11517003 |
| 82 | high-density lipoprotein particle remodeling (GO:0034375) | 3.11054932 |
| 83 | granulocyte activation (GO:0036230) | 3.07967087 |
| 84 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.07238631 |
| 85 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.01942105 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 3.00009446 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.99720623 |
| 88 | alpha-amino acid catabolic process (GO:1901606) | 2.99051408 |
| 89 | glutathione derivative metabolic process (GO:1901685) | 2.98786642 |
| 90 | glutathione derivative biosynthetic process (GO:1901687) | 2.98786642 |
| 91 | negative regulation of cholesterol transport (GO:0032375) | 2.98697520 |
| 92 | negative regulation of sterol transport (GO:0032372) | 2.98697520 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98162798 |
| 94 | intestinal absorption (GO:0050892) | 2.97590749 |
| 95 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.97334334 |
| 96 | negative regulation of fibrinolysis (GO:0051918) | 2.96830927 |
| 97 | germinal center formation (GO:0002467) | 2.96652238 |
| 98 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.96044268 |
| 99 | response to nitrosative stress (GO:0051409) | 2.95796712 |
| 100 | amino-acid betaine metabolic process (GO:0006577) | 2.94793126 |
| 101 | coenzyme catabolic process (GO:0009109) | 2.94502668 |
| 102 | positive regulation of humoral immune response (GO:0002922) | 2.94177281 |
| 103 | tyrosine metabolic process (GO:0006570) | 2.92253633 |
| 104 | ethanol oxidation (GO:0006069) | 2.92231165 |
| 105 | alpha-amino acid biosynthetic process (GO:1901607) | 2.90963576 |
| 106 | cellular amino acid catabolic process (GO:0009063) | 2.90510858 |
| 107 | regulation of mast cell degranulation (GO:0043304) | 2.90067800 |
| 108 | cholesterol homeostasis (GO:0042632) | 2.89803751 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.89290299 |
| 110 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87983639 |
| 111 | sterol homeostasis (GO:0055092) | 2.86858528 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.84789522 |
| 113 | very long-chain fatty acid metabolic process (GO:0000038) | 2.84252932 |
| 114 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.83218060 |
| 115 | negative thymic T cell selection (GO:0045060) | 2.82875400 |
| 116 | regulation of interferon-alpha production (GO:0032647) | 2.81019004 |
| 117 | plasma lipoprotein particle assembly (GO:0034377) | 2.80818839 |
| 118 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79591898 |
| 119 | cellular amino acid biosynthetic process (GO:0008652) | 2.78951801 |
| 120 | leukocyte degranulation (GO:0043299) | 2.78919270 |
| 121 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78226788 |
| 122 | response to host immune response (GO:0052572) | 2.78095388 |
| 123 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78095388 |
| 124 | glycerophospholipid catabolic process (GO:0046475) | 2.77519186 |
| 125 | aspartate family amino acid catabolic process (GO:0009068) | 2.77490774 |
| 126 | drug metabolic process (GO:0017144) | 2.77152612 |
| 127 | type I interferon signaling pathway (GO:0060337) | 2.76788648 |
| 128 | cellular response to type I interferon (GO:0071357) | 2.76788648 |
| 129 | regulation of fibrinolysis (GO:0051917) | 2.76048913 |
| 130 | leukocyte aggregation (GO:0070486) | 2.75670737 |
| 131 | cholesterol efflux (GO:0033344) | 2.75245538 |
| 132 | response to type I interferon (GO:0034340) | 2.75079625 |
| 133 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.73720460 |
| 134 | acylglycerol homeostasis (GO:0055090) | 2.73708558 |
| 135 | triglyceride homeostasis (GO:0070328) | 2.73708558 |
| 136 | detection of biotic stimulus (GO:0009595) | 2.72976210 |
| 137 | plasma lipoprotein particle remodeling (GO:0034369) | 2.72688777 |
| 138 | protein-lipid complex remodeling (GO:0034368) | 2.72688777 |
| 139 | macromolecular complex remodeling (GO:0034367) | 2.72688777 |
| 140 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.72217046 |
| 141 | drug catabolic process (GO:0042737) | 2.71760118 |
| 142 | bile acid and bile salt transport (GO:0015721) | 2.71573694 |
| 143 | folic acid-containing compound metabolic process (GO:0006760) | 2.70198511 |
| 144 | plasma lipoprotein particle clearance (GO:0034381) | 2.70085742 |
| 145 | histone H3-K36 demethylation (GO:0070544) | 2.69295265 |
| 146 | regulation of protein activation cascade (GO:2000257) | 2.69011470 |
| 147 | regulation of lipoprotein metabolic process (GO:0050746) | 2.68965960 |
| 148 | negative T cell selection (GO:0043383) | 2.68882923 |
| 149 | sulfur amino acid metabolic process (GO:0000096) | 2.68417616 |
| 150 | pentose metabolic process (GO:0019321) | 2.67914140 |
| 151 | L-methionine biosynthetic process (GO:0071265) | 2.66294403 |
| 152 | amino acid salvage (GO:0043102) | 2.66294403 |
| 153 | L-methionine salvage (GO:0071267) | 2.66294403 |
| 154 | macrophage activation (GO:0042116) | 2.65544972 |
| 155 | reverse cholesterol transport (GO:0043691) | 2.65428049 |
| 156 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.65149016 |
| 157 | positive regulation of interferon-beta production (GO:0032728) | 2.65050340 |
| 158 | piRNA metabolic process (GO:0034587) | 2.64106265 |
| 159 | cytokine biosynthetic process (GO:0042089) | 2.62550804 |
| 160 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.62144773 |
| 161 | protein-lipid complex assembly (GO:0065005) | 2.62127691 |
| 162 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.61779450 |
| 163 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.61779450 |
| 164 | iron coordination entity transport (GO:1901678) | 2.61625241 |
| 165 | positive regulation of B cell differentiation (GO:0045579) | 2.61228480 |
| 166 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.60924937 |
| 167 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.60590062 |
| 168 | complement activation, alternative pathway (GO:0006957) | 2.60488469 |
| 169 | regulation of leukocyte degranulation (GO:0043300) | 2.60294819 |
| 170 | aspartate family amino acid metabolic process (GO:0009066) | 2.59857469 |
| 171 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59757938 |
| 172 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.59678121 |
| 173 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.59377987 |
| 174 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.59111705 |
| 175 | sulfur amino acid biosynthetic process (GO:0000097) | 2.59013287 |
| 176 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.58096711 |
| 177 | T-helper 1 type immune response (GO:0042088) | 2.58008784 |
| 178 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.57825759 |
| 179 | cellular modified amino acid catabolic process (GO:0042219) | 2.57769323 |
| 180 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.57658303 |
| 181 | cofactor catabolic process (GO:0051187) | 2.57272548 |
| 182 | positive regulation of type 2 immune response (GO:0002830) | 2.56621060 |
| 183 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.55434770 |
| 184 | cell wall macromolecule metabolic process (GO:0044036) | 2.55348352 |
| 185 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.55010838 |
| 186 | oligosaccharide catabolic process (GO:0009313) | 2.53104168 |
| 187 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.52619667 |
| 188 | mast cell activation (GO:0045576) | 2.52465069 |
| 189 | positive T cell selection (GO:0043368) | 2.51392517 |
| 190 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50540450 |
| 191 | neutrophil mediated immunity (GO:0002446) | 2.50006095 |
| 192 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.49783503 |
| 193 | response to host defenses (GO:0052200) | 2.49016128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.47996532 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.04985707 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.94339842 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.72372369 |
| 5 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.68784689 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.62030464 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.51128129 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.38985917 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99268535 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.97794098 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.95865731 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.91771613 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.90319670 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90295664 |
| 15 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.79767115 |
| 16 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.79767115 |
| 17 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.79767115 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62688412 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.58228588 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.53973917 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.47027584 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.46865108 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42014799 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31148240 |
| 25 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28429925 |
| 26 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.25485326 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22233043 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22025976 |
| 29 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.21841830 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17738708 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17257469 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.16233964 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13932380 |
| 34 | * MAF_26560356_Chip-Seq_TH1_Human | 2.09150076 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03182465 |
| 36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.01080140 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99424647 |
| 38 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96774231 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96676118 |
| 40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.94969795 |
| 41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.94488287 |
| 42 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.90229901 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90185331 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.89303341 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.89204504 |
| 46 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88622421 |
| 47 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.88565724 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87598534 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87271788 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83217115 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81139240 |
| 52 | * MYB_26560356_Chip-Seq_TH2_Human | 1.80818255 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.79420927 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78879275 |
| 55 | * MYB_26560356_Chip-Seq_TH1_Human | 1.76169313 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76142887 |
| 57 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.75373365 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75177961 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73132423 |
| 60 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.73071277 |
| 61 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71278302 |
| 62 | * MAF_26560356_Chip-Seq_TH2_Human | 1.65566232 |
| 63 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.62274744 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.60571780 |
| 65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.60553724 |
| 66 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56477961 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56387724 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55493850 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54791553 |
| 70 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54783862 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53982771 |
| 72 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.53531643 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53188039 |
| 74 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52816406 |
| 75 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.52806959 |
| 76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.49268464 |
| 77 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.49006521 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.48975104 |
| 79 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.45608410 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44618971 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44181259 |
| 82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42940029 |
| 83 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.41998545 |
| 84 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.41734979 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39506660 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39226811 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39077708 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38314500 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36475983 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.36114323 |
| 91 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.35480381 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34778809 |
| 93 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33923734 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33180120 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32968883 |
| 96 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32916258 |
| 97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32782798 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32693488 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32505826 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32399413 |
| 101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32010540 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31955760 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30450954 |
| 104 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30412515 |
| 105 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29869841 |
| 106 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29824871 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27310420 |
| 108 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.26745531 |
| 109 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.25919022 |
| 110 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.23633879 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23005575 |
| 112 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.22462156 |
| 113 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21745092 |
| 114 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.21056147 |
| 115 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19065000 |
| 116 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.19030583 |
| 117 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.18720329 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18691032 |
| 119 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18641170 |
| 120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16839444 |
| 121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15874924 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15231451 |
| 123 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.13252848 |
| 124 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13038148 |
| 125 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12840728 |
| 126 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12346276 |
| 127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11785428 |
| 128 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.10501570 |
| 129 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10432690 |
| 130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10004170 |
| 131 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09940238 |
| 132 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09311113 |
| 133 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.09236261 |
| 134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07937209 |
| 135 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07786088 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06609529 |
| 137 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06531907 |
| 138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05892072 |
| 139 | P68_20966046_ChIP-Seq_HELA_Human | 1.05890159 |
| 140 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05177902 |
| 141 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04154291 |
| 142 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.03996689 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03823821 |
| 144 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03784439 |
| 145 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03635292 |
| 146 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.02564583 |
| 147 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02196305 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98130625 |
| 149 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96896611 |
| 150 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.96602918 |
| 151 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95775316 |
| 152 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95326157 |
| 153 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93645030 |
| 154 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93404913 |
| 155 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.92650865 |
| 156 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92247789 |
| 157 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.91467749 |
| 158 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91296767 |
| 159 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.91200499 |
| 160 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90301811 |
| 161 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.89104041 |
| 162 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.87628838 |
| 163 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.87144428 |
| 164 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87111411 |
| 165 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85550256 |
| 166 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85391775 |
| 167 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.84913022 |
| 168 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83530804 |
| 169 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.83082045 |
| 170 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82786177 |
| 171 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81996359 |
| 172 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.81710215 |
| 173 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.81604620 |
| 174 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.81592283 |
| 175 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81562819 |
| 176 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80389136 |
| 177 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.76000667 |
| 178 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.74606661 |
| 179 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.71959440 |
| 180 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71697035 |
| 181 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71495414 |
| 182 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71394212 |
| 183 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71024798 |
| 184 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.70247830 |
| 185 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.69923256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.07245745 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 5.51373680 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.17921788 |
| 4 | MP0003303_peritoneal_inflammation | 4.26157963 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.87116042 |
| 6 | MP0005365_abnormal_bile_salt | 3.51237724 |
| 7 | MP0009840_abnormal_foam_cell | 3.37513897 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.36899321 |
| 9 | MP0005410_abnormal_fertilization | 3.22559832 |
| 10 | MP0003436_decreased_susceptibility_to | 3.06225215 |
| 11 | MP0003724_increased_susceptibility_to | 2.98406918 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.73653465 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.65183224 |
| 14 | MP0005671_abnormal_response_to | 2.55666479 |
| 15 | MP0002419_abnormal_innate_immunity | 2.42756988 |
| 16 | MP0003252_abnormal_bile_duct | 2.40305457 |
| 17 | MP0000685_abnormal_immune_system | 2.38471712 |
| 18 | MP0005025_abnormal_response_to | 2.34365976 |
| 19 | MP0001800_abnormal_humoral_immune | 2.34354548 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.30166066 |
| 21 | MP0005332_abnormal_amino_acid | 2.24311792 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.23501893 |
| 23 | MP0003718_maternal_effect | 2.20198293 |
| 24 | MP0001790_abnormal_immune_system | 2.17280967 |
| 25 | MP0005387_immune_system_phenotype | 2.17280967 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.15064639 |
| 27 | MP0002723_abnormal_immune_serum | 2.11804828 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.08674700 |
| 29 | MP0010329_abnormal_lipoprotein_level | 2.07707077 |
| 30 | MP0005451_abnormal_body_composition | 2.06518869 |
| 31 | MP0005464_abnormal_platelet_physiology | 2.00402966 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.99884237 |
| 33 | MP0009785_altered_susceptibility_to | 1.97925034 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.95831693 |
| 35 | MP0008057_abnormal_DNA_replication | 1.95828427 |
| 36 | MP0001819_abnormal_immune_cell | 1.95351641 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.94617624 |
| 38 | MP0008260_abnormal_autophagy | 1.90749280 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.89134920 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.86101427 |
| 41 | MP0004947_skin_inflammation | 1.83369569 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.80808089 |
| 43 | MP0002398_abnormal_bone_marrow | 1.72668947 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.69086548 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.68223426 |
| 46 | MP0000920_abnormal_myelination | 1.66037489 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.64402306 |
| 48 | MP0000716_abnormal_immune_system | 1.61237728 |
| 49 | MP0003186_abnormal_redox_activity | 1.57997701 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.55682317 |
| 51 | MP0003136_yellow_coat_color | 1.54278377 |
| 52 | MP0001661_extended_life_span | 1.53575465 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.53251145 |
| 54 | MP0004381_abnormal_hair_follicle | 1.52900062 |
| 55 | MP0000609_abnormal_liver_physiology | 1.51944900 |
| 56 | MP0001929_abnormal_gametogenesis | 1.51791493 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.49059714 |
| 58 | MP0002722_abnormal_immune_system | 1.48302519 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.48209044 |
| 60 | MP0003195_calcinosis | 1.47584439 |
| 61 | MP0002405_respiratory_system_inflammati | 1.47288405 |
| 62 | MP0003111_abnormal_nucleus_morphology | 1.47275873 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.43334219 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.39128401 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.38173133 |
| 66 | MP0002429_abnormal_blood_cell | 1.38097581 |
| 67 | MP0010094_abnormal_chromosome_stability | 1.36131854 |
| 68 | MP0008469_abnormal_protein_level | 1.35135412 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.32968557 |
| 70 | MP0003077_abnormal_cell_cycle | 1.32758633 |
| 71 | MP0001764_abnormal_homeostasis | 1.31064522 |
| 72 | MP0000462_abnormal_digestive_system | 1.30455619 |
| 73 | MP0005083_abnormal_biliary_tract | 1.27880164 |
| 74 | MP0009278_abnormal_bone_marrow | 1.26817317 |
| 75 | MP0003698_abnormal_male_reproductive | 1.26645426 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.25738436 |
| 77 | MP0003828_pulmonary_edema | 1.25526443 |
| 78 | MP0002653_abnormal_ependyma_morphology | 1.24573241 |
| 79 | MP0003011_delayed_dark_adaptation | 1.23810546 |
| 80 | MP0005408_hypopigmentation | 1.23434267 |
| 81 | MP0004043_abnormal_pH_regulation | 1.19834851 |
| 82 | MP0005310_abnormal_salivary_gland | 1.19578628 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.19053520 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.17299714 |
| 85 | MP0002166_altered_tumor_susceptibility | 1.16886582 |
| 86 | MP0001730_embryonic_growth_arrest | 1.16754549 |
| 87 | MP0002009_preneoplasia | 1.15056866 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 1.14642525 |
| 89 | MP0003868_abnormal_feces_composition | 1.14314990 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 1.11942961 |
| 91 | MP0001545_abnormal_hematopoietic_system | 1.11942961 |
| 92 | MP0005647_abnormal_sex_gland | 1.09806190 |
| 93 | MP0003300_gastrointestinal_ulcer | 1.08871437 |
| 94 | MP0001145_abnormal_male_reproductive | 1.08713039 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 1.06113160 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.04952695 |
| 97 | MP0005174_abnormal_tail_pigmentation | 1.04520712 |
| 98 | MP0009643_abnormal_urine_homeostasis | 1.03439035 |
| 99 | MP0000858_altered_metastatic_potential | 1.02646499 |
| 100 | MP0002254_reproductive_system_inflammat | 1.02399764 |
| 101 | MP0000015_abnormal_ear_pigmentation | 1.02299602 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 1.01406033 |
| 103 | MP0009764_decreased_sensitivity_to | 0.99893571 |
| 104 | MP0002210_abnormal_sex_determination | 0.99351995 |
| 105 | MP0000653_abnormal_sex_gland | 0.98294464 |
| 106 | MP0003690_abnormal_glial_cell | 0.98167014 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97698591 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.96978632 |
| 109 | MP0004147_increased_porphyrin_level | 0.96233565 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.92932528 |
| 111 | MP0005395_other_phenotype | 0.89253759 |
| 112 | MP0002161_abnormal_fertility/fecundity | 0.88179017 |
| 113 | MP0008932_abnormal_embryonic_tissue | 0.87631742 |
| 114 | MP0005266_abnormal_metabolism | 0.87254613 |
| 115 | MP0001873_stomach_inflammation | 0.86715586 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.86296447 |
| 117 | MP0003866_abnormal_defecation | 0.86178104 |
| 118 | MP0005075_abnormal_melanosome_morpholog | 0.85683726 |
| 119 | MP0000579_abnormal_nail_morphology | 0.84672118 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.83246527 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.82625141 |
| 122 | MP0003646_muscle_fatigue | 0.80937400 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.80624025 |
| 124 | MP0008004_abnormal_stomach_pH | 0.80604609 |
| 125 | MP0000598_abnormal_liver_morphology | 0.79651157 |
| 126 | MP0002006_tumorigenesis | 0.79552846 |
| 127 | MP0009697_abnormal_copulation | 0.78480850 |
| 128 | MP0002019_abnormal_tumor_incidence | 0.77506024 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.77297000 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.74796439 |
| 131 | MP0008058_abnormal_DNA_repair | 0.74713580 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 0.74600088 |
| 133 | MP0001485_abnormal_pinna_reflex | 0.74008568 |
| 134 | MP0003448_altered_tumor_morphology | 0.73573715 |
| 135 | MP0001851_eye_inflammation | 0.73503715 |
| 136 | MP0000465_gastrointestinal_hemorrhage | 0.72299295 |
| 137 | MP0000490_abnormal_crypts_of | 0.72089284 |
| 138 | MP0002332_abnormal_exercise_endurance | 0.71872003 |
| 139 | MP0000350_abnormal_cell_proliferation | 0.71087424 |
| 140 | MP0005376_homeostasis/metabolism_phenot | 0.70087032 |
| 141 | MP0000377_abnormal_hair_follicle | 0.69804126 |
| 142 | MP0002796_impaired_skin_barrier | 0.69797888 |
| 143 | MP0004808_abnormal_hematopoietic_stem | 0.69795581 |
| 144 | MP0001672_abnormal_embryogenesis/_devel | 0.69008661 |
| 145 | MP0005380_embryogenesis_phenotype | 0.69008661 |
| 146 | MP0005023_abnormal_wound_healing | 0.68619489 |
| 147 | MP0003937_abnormal_limbs/digits/tail_de | 0.68142261 |
| 148 | MP0002132_abnormal_respiratory_system | 0.68130160 |
| 149 | MP0000604_amyloidosis | 0.67775435 |
| 150 | MP0003705_abnormal_hypodermis_morpholog | 0.66858852 |
| 151 | MP0005670_abnormal_white_adipose | 0.65209781 |
| 152 | MP0001663_abnormal_digestive_system | 0.64481747 |
| 153 | MP0001346_abnormal_lacrimal_gland | 0.63782868 |
| 154 | MP0009763_increased_sensitivity_to | 0.63649084 |
| 155 | MP0006082_CNS_inflammation | 0.63326524 |
| 156 | MP0004133_heterotaxia | 0.61858483 |
| 157 | MP0006072_abnormal_retinal_apoptosis | 0.61289939 |
| 158 | MP0002085_abnormal_embryonic_tissue | 0.61195639 |
| 159 | MP0010030_abnormal_orbit_morphology | 0.61154826 |
| 160 | MP0008877_abnormal_DNA_methylation | 0.59826297 |
| 161 | MP0008873_increased_physiological_sensi | 0.59579598 |
| 162 | MP0002092_abnormal_eye_morphology | 0.59287024 |
| 163 | MP0002138_abnormal_hepatobiliary_system | 0.59222264 |
| 164 | MP0001697_abnormal_embryo_size | 0.58833113 |
| 165 | MP0003699_abnormal_female_reproductive | 0.56239456 |
| 166 | MP0000383_abnormal_hair_follicle | 0.54699041 |
| 167 | MP0001293_anophthalmia | 0.54431327 |
| 168 | MP0003786_premature_aging | 0.54071433 |
| 169 | MP0004885_abnormal_endolymph | 0.53580291 |
| 170 | MP0000647_abnormal_sebaceous_gland | 0.53483633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.64379288 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 5.10245472 |
| 3 | Abnormality of macrophages (HP:0004311) | 5.09539927 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.08723876 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.72047877 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.59675055 |
| 7 | Xanthomatosis (HP:0000991) | 4.52901870 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.38748882 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.33506331 |
| 10 | Deep venous thrombosis (HP:0002625) | 4.20387146 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 4.05111899 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.05111899 |
| 13 | Hyperglycinuria (HP:0003108) | 4.00042794 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.79349524 |
| 15 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.61829623 |
| 16 | Hyperglycinemia (HP:0002154) | 3.57917781 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.55404435 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.53078275 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.39842789 |
| 20 | Myositis (HP:0100614) | 3.36842088 |
| 21 | Fat malabsorption (HP:0002630) | 3.34756810 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.33662355 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.33255811 |
| 24 | Hyperammonemia (HP:0001987) | 3.26215053 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.23775900 |
| 26 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.21283705 |
| 27 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.21283705 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.21103268 |
| 29 | Optic neuritis (HP:0100653) | 3.21103268 |
| 30 | Stomatitis (HP:0010280) | 3.18427372 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.17391817 |
| 32 | Orchitis (HP:0100796) | 3.16265583 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.15095554 |
| 34 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.13427035 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11743650 |
| 36 | Meningitis (HP:0001287) | 3.09230784 |
| 37 | Progressive external ophthalmoplegia (HP:0000590) | 3.07694938 |
| 38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.02594655 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 3.00874218 |
| 40 | Obstructive lung disease (HP:0006536) | 2.99890490 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99890490 |
| 42 | Prostate neoplasm (HP:0100787) | 2.95958165 |
| 43 | Cellulitis (HP:0100658) | 2.89253229 |
| 44 | Gingival bleeding (HP:0000225) | 2.86269013 |
| 45 | Parakeratosis (HP:0001036) | 2.85717714 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.83495093 |
| 47 | Vascular calcification (HP:0004934) | 2.79586136 |
| 48 | Recurrent fungal infections (HP:0002841) | 2.78295836 |
| 49 | Malnutrition (HP:0004395) | 2.75356907 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.74138643 |
| 51 | Impulsivity (HP:0100710) | 2.73212803 |
| 52 | Ileus (HP:0002595) | 2.71611860 |
| 53 | Recurrent skin infections (HP:0001581) | 2.70920731 |
| 54 | Vasculitis (HP:0002633) | 2.68515429 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.67951547 |
| 56 | Breast hypoplasia (HP:0003187) | 2.64643982 |
| 57 | Persistence of primary teeth (HP:0006335) | 2.62236278 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.62011280 |
| 59 | Epistaxis (HP:0000421) | 2.61938752 |
| 60 | Epidermoid cyst (HP:0200040) | 2.60200711 |
| 61 | Petechiae (HP:0000967) | 2.58469637 |
| 62 | Hypoalphalipoproteinemia (HP:0003233) | 2.57735337 |
| 63 | Osteomyelitis (HP:0002754) | 2.57085866 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.55779570 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55699116 |
| 66 | Loss of speech (HP:0002371) | 2.55551480 |
| 67 | Increased serum ferritin (HP:0003281) | 2.52511477 |
| 68 | Nausea (HP:0002018) | 2.52168438 |
| 69 | Slow saccadic eye movements (HP:0000514) | 2.51358352 |
| 70 | Steatorrhea (HP:0002570) | 2.50409059 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50337406 |
| 72 | Gastrointestinal stroma tumor (HP:0100723) | 2.48809943 |
| 73 | Increased IgE level (HP:0003212) | 2.48734287 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.47368641 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.47227886 |
| 76 | Abnormality of the corticospinal tract (HP:0002492) | 2.43803556 |
| 77 | Anorexia (HP:0002039) | 2.43559228 |
| 78 | Cerebral hypomyelination (HP:0006808) | 2.41823560 |
| 79 | Colitis (HP:0002583) | 2.41666316 |
| 80 | Spastic paraparesis (HP:0002313) | 2.40657026 |
| 81 | Recurrent viral infections (HP:0004429) | 2.40617579 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.40425532 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.39934207 |
| 84 | Increased serum pyruvate (HP:0003542) | 2.37246457 |
| 85 | Abnormality of glycolysis (HP:0004366) | 2.37246457 |
| 86 | Encephalitis (HP:0002383) | 2.36271482 |
| 87 | Urticaria (HP:0001025) | 2.35880055 |
| 88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35608655 |
| 89 | Thrombocytosis (HP:0001894) | 2.34831021 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.34798473 |
| 91 | Complement deficiency (HP:0004431) | 2.34042568 |
| 92 | Hypercholesterolemia (HP:0003124) | 2.33639147 |
| 93 | T lymphocytopenia (HP:0005403) | 2.33536089 |
| 94 | Abnormality of the prostate (HP:0008775) | 2.32202721 |
| 95 | Neurofibrillary tangles (HP:0002185) | 2.29679608 |
| 96 | Acanthocytosis (HP:0001927) | 2.29054318 |
| 97 | Peripheral hypomyelination (HP:0007182) | 2.26745149 |
| 98 | Abnormality of the common coagulation pathway (HP:0010990) | 2.26238312 |
| 99 | Abnormality of T cell number (HP:0011839) | 2.25316176 |
| 100 | Keratoconjunctivitis sicca (HP:0001097) | 2.23943028 |
| 101 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23485331 |
| 102 | Pustule (HP:0200039) | 2.22431838 |
| 103 | Hypochromic anemia (HP:0001931) | 2.22189722 |
| 104 | Abnormality of serum amino acid levels (HP:0003112) | 2.21673767 |
| 105 | Lethargy (HP:0001254) | 2.21256131 |
| 106 | Poikilocytosis (HP:0004447) | 2.21047634 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 2.20419266 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.20148900 |
| 109 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19867139 |
| 110 | Amyloidosis (HP:0011034) | 2.18831142 |
| 111 | Premature loss of primary teeth (HP:0006323) | 2.18829331 |
| 112 | Ketosis (HP:0001946) | 2.18582846 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 2.15672218 |
| 114 | Abnormality of nucleobase metabolism (HP:0010932) | 2.14803277 |
| 115 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.12780228 |
| 116 | Gingivitis (HP:0000230) | 2.12054844 |
| 117 | Irritability (HP:0000737) | 2.09207716 |
| 118 | Arterial thrombosis (HP:0004420) | 2.08413142 |
| 119 | Autoimmune hemolytic anemia (HP:0001890) | 2.06724970 |
| 120 | Spastic tetraparesis (HP:0001285) | 2.05808408 |
| 121 | Abnormality of glycolipid metabolism (HP:0010969) | 2.04751254 |
| 122 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.04751254 |
| 123 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.04751254 |
| 124 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04025373 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04025373 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02950952 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02950952 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02950952 |
| 129 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.02745116 |
| 130 | Papilloma (HP:0012740) | 2.02558356 |
| 131 | Verrucae (HP:0200043) | 2.02558356 |
| 132 | Purpura (HP:0000979) | 2.02015810 |
| 133 | Hyperbilirubinemia (HP:0002904) | 2.01928434 |
| 134 | Spontaneous abortion (HP:0005268) | 2.01569426 |
| 135 | Sepsis (HP:0100806) | 2.00587929 |
| 136 | Polyneuropathy (HP:0001271) | 2.00472416 |
| 137 | Megaloblastic anemia (HP:0001889) | 2.00370019 |
| 138 | Recurrent pneumonia (HP:0006532) | 1.98502310 |
| 139 | Skin rash (HP:0000988) | 1.98062244 |
| 140 | Absent/shortened dynein arms (HP:0200106) | 1.97648946 |
| 141 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.97648946 |
| 142 | Absent radius (HP:0003974) | 1.96975981 |
| 143 | Abnormality of the fingertips (HP:0001211) | 1.96353047 |
| 144 | Gangrene (HP:0100758) | 1.95964651 |
| 145 | Pulmonary infiltrates (HP:0002113) | 1.95936969 |
| 146 | Amniotic constriction ring (HP:0009775) | 1.95203670 |
| 147 | Abnormality of placental membranes (HP:0011409) | 1.95203670 |
| 148 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.94829010 |
| 149 | Abnormality of T cells (HP:0002843) | 1.94705414 |
| 150 | Morphological abnormality of the inner ear (HP:0011390) | 1.94695409 |
| 151 | Abnormality of cochlea (HP:0000375) | 1.93957843 |
| 152 | IgM deficiency (HP:0002850) | 1.93353561 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.93196072 |
| 154 | Abnormality of the intrinsic pathway (HP:0010989) | 1.93142991 |
| 155 | Leukocytosis (HP:0001974) | 1.92593161 |
| 156 | Chest pain (HP:0100749) | 1.91552897 |
| 157 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91044783 |
| 158 | Recurrent bronchitis (HP:0002837) | 1.90894243 |
| 159 | Prolonged neonatal jaundice (HP:0006579) | 1.90865374 |
| 160 | Keratoconjunctivitis (HP:0001096) | 1.89047625 |
| 161 | Chronic bronchitis (HP:0004469) | 1.88461315 |
| 162 | Pulmonary embolism (HP:0002204) | 1.87465004 |
| 163 | Periodontitis (HP:0000704) | 1.86380999 |
| 164 | Aplasia involving forearm bones (HP:0009822) | 1.85557718 |
| 165 | Absent forearm bone (HP:0003953) | 1.85557718 |
| 166 | CNS hypomyelination (HP:0003429) | 1.84638128 |
| 167 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84069350 |
| 168 | Dicarboxylic aciduria (HP:0003215) | 1.84069350 |
| 169 | Spastic diplegia (HP:0001264) | 1.81435023 |
| 170 | Esophageal atresia (HP:0002032) | 1.81432887 |
| 171 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79536714 |
| 172 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.79428373 |
| 173 | Carpal bone hypoplasia (HP:0001498) | 1.78765956 |
| 174 | Hepatosplenomegaly (HP:0001433) | 1.77727794 |
| 175 | Abnormality of complement system (HP:0005339) | 1.77646352 |
| 176 | Rickets (HP:0002748) | 1.77200882 |
| 177 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73322324 |
| 178 | Hypoglycemic coma (HP:0001325) | 1.72957163 |
| 179 | Brushfield spots (HP:0001088) | 1.71514846 |
| 180 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68443146 |
| 181 | Autoamputation (HP:0001218) | 1.67726248 |
| 182 | Vertebral clefting (HP:0008428) | 1.66459929 |
| 183 | Seborrheic dermatitis (HP:0001051) | 1.66062240 |
| 184 | Clitoromegaly (HP:0000057) | 1.65492020 |
| 185 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.64443646 |
| 186 | Adrenal hypoplasia (HP:0000835) | 1.63919360 |
| 187 | Abnormality of purine metabolism (HP:0004352) | 1.63509007 |
| 188 | Sensory axonal neuropathy (HP:0003390) | 1.62646624 |
| 189 | Joint hemorrhage (HP:0005261) | 1.61317729 |
| 190 | Peripheral demyelination (HP:0011096) | 1.60342693 |
| 191 | Cerebral edema (HP:0002181) | 1.60150539 |
| 192 | Paraparesis (HP:0002385) | 1.60090068 |
| 193 | Birth length less than 3rd percentile (HP:0003561) | 1.59877474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.01764573 |
| 2 | BUB1 | 3.90706162 |
| 3 | RIPK4 | 3.74938111 |
| 4 | WEE1 | 2.96752275 |
| 5 | MAP4K1 | 2.95242084 |
| 6 | OXSR1 | 2.88027104 |
| 7 | MAP2K3 | 2.64588769 |
| 8 | BCKDK | 2.60182102 |
| 9 | EPHB1 | 2.43824475 |
| 10 | PBK | 2.41139383 |
| 11 | MAP3K13 | 2.38357997 |
| 12 | ICK | 2.37554887 |
| 13 | IRAK4 | 2.36216102 |
| 14 | STK10 | 2.20040146 |
| 15 | TESK1 | 2.19538334 |
| 16 | PRPF4B | 2.18368653 |
| 17 | TTK | 2.13227270 |
| 18 | LATS1 | 2.06020131 |
| 19 | MST4 | 2.00651373 |
| 20 | AKT3 | 2.00097534 |
| 21 | MAP3K14 | 1.98475743 |
| 22 | EPHA2 | 1.96311630 |
| 23 | TBK1 | 1.89125900 |
| 24 | MET | 1.89073980 |
| 25 | CDK12 | 1.88701410 |
| 26 | NEK2 | 1.86971853 |
| 27 | CDC7 | 1.79921671 |
| 28 | TNK2 | 1.79028561 |
| 29 | TRIB3 | 1.75365783 |
| 30 | PNCK | 1.71767477 |
| 31 | IKBKE | 1.67089672 |
| 32 | MAP2K2 | 1.59247680 |
| 33 | EIF2AK3 | 1.57351928 |
| 34 | EIF2AK1 | 1.56840869 |
| 35 | BRSK2 | 1.52663570 |
| 36 | ZAP70 | 1.52133053 |
| 37 | PDK4 | 1.51090961 |
| 38 | PDK3 | 1.51090961 |
| 39 | IRAK3 | 1.44790479 |
| 40 | SMG1 | 1.44120974 |
| 41 | TAOK1 | 1.41201933 |
| 42 | SIK3 | 1.40529486 |
| 43 | ERN1 | 1.33970957 |
| 44 | GRK6 | 1.32856183 |
| 45 | MARK3 | 1.32802422 |
| 46 | MAP3K11 | 1.31276849 |
| 47 | SIK1 | 1.29566810 |
| 48 | MAP3K8 | 1.29299313 |
| 49 | MUSK | 1.27224916 |
| 50 | IKBKB | 1.26864087 |
| 51 | KSR2 | 1.23366705 |
| 52 | WNK4 | 1.23138499 |
| 53 | MAP3K1 | 1.22451911 |
| 54 | CHEK2 | 1.22426781 |
| 55 | SYK | 1.21938801 |
| 56 | MAPKAPK5 | 1.20805200 |
| 57 | PDK2 | 1.17989656 |
| 58 | PRKD3 | 1.16676287 |
| 59 | PDPK1 | 1.14967118 |
| 60 | MATK | 1.14764305 |
| 61 | JAK3 | 1.11807151 |
| 62 | TAOK2 | 1.11094340 |
| 63 | PLK1 | 1.08862264 |
| 64 | PDK1 | 1.07053025 |
| 65 | ERBB4 | 1.06701292 |
| 66 | HCK | 1.06523906 |
| 67 | MAPKAPK3 | 1.03671176 |
| 68 | CDK7 | 1.02090654 |
| 69 | DYRK3 | 1.01396059 |
| 70 | BCR | 0.98784610 |
| 71 | BTK | 0.97933669 |
| 72 | AURKB | 0.97164690 |
| 73 | IRAK2 | 0.96126065 |
| 74 | STK3 | 0.96011112 |
| 75 | ARAF | 0.93814462 |
| 76 | VRK1 | 0.93115317 |
| 77 | RAF1 | 0.92952604 |
| 78 | MELK | 0.92139787 |
| 79 | TLK1 | 0.91807563 |
| 80 | MAPK15 | 0.91666251 |
| 81 | LYN | 0.91572321 |
| 82 | PLK4 | 0.90725470 |
| 83 | DDR2 | 0.89273764 |
| 84 | BRD4 | 0.88737000 |
| 85 | TXK | 0.88249281 |
| 86 | AURKA | 0.87574981 |
| 87 | FES | 0.86686430 |
| 88 | PIM1 | 0.85245163 |
| 89 | CAMK1D | 0.84977025 |
| 90 | CSNK1G1 | 0.83555394 |
| 91 | EEF2K | 0.81280080 |
| 92 | JAK2 | 0.80372492 |
| 93 | PAK1 | 0.79480556 |
| 94 | ITK | 0.78690393 |
| 95 | CHEK1 | 0.78398421 |
| 96 | JAK1 | 0.76762273 |
| 97 | FGR | 0.76622284 |
| 98 | FGFR2 | 0.76541419 |
| 99 | CSNK1G3 | 0.75139091 |
| 100 | CDK19 | 0.74975321 |
| 101 | LIMK1 | 0.74962702 |
| 102 | ACVR1B | 0.74537016 |
| 103 | TAOK3 | 0.72645761 |
| 104 | YES1 | 0.72521699 |
| 105 | WNK1 | 0.71325020 |
| 106 | RIPK1 | 0.70596295 |
| 107 | LCK | 0.70424771 |
| 108 | STK4 | 0.68280090 |
| 109 | FGFR4 | 0.68139564 |
| 110 | MARK2 | 0.67592434 |
| 111 | PKN1 | 0.67533724 |
| 112 | FRK | 0.67387252 |
| 113 | CSK | 0.67324947 |
| 114 | MAP3K3 | 0.66594100 |
| 115 | MAPK12 | 0.62231807 |
| 116 | IRAK1 | 0.61665151 |
| 117 | CDC42BPA | 0.61319956 |
| 118 | BMPR2 | 0.60814596 |
| 119 | PIK3CG | 0.60203094 |
| 120 | NEK6 | 0.59615480 |
| 121 | DYRK1B | 0.59483851 |
| 122 | MAPK7 | 0.58595227 |
| 123 | GSK3A | 0.58287361 |
| 124 | BMX | 0.57709220 |
| 125 | STK16 | 0.57040541 |
| 126 | KIT | 0.55106106 |
| 127 | SRPK1 | 0.54430127 |
| 128 | RPS6KA5 | 0.54271279 |
| 129 | CSNK1A1L | 0.54131627 |
| 130 | MAPK11 | 0.53761509 |
| 131 | MTOR | 0.52559217 |
| 132 | CDK4 | 0.51241289 |
| 133 | MAP3K2 | 0.51237450 |
| 134 | ZAK | 0.50425517 |
| 135 | BRAF | 0.47238758 |
| 136 | CHUK | 0.47029030 |
| 137 | MAP3K10 | 0.46714808 |
| 138 | MAP2K6 | 0.45967821 |
| 139 | CLK1 | 0.45941490 |
| 140 | BLK | 0.45626393 |
| 141 | ATR | 0.44622093 |
| 142 | TEC | 0.44565413 |
| 143 | CDK2 | 0.43945140 |
| 144 | CSF1R | 0.43538003 |
| 145 | RPS6KL1 | 0.43226205 |
| 146 | RPS6KC1 | 0.43226205 |
| 147 | PLK3 | 0.43044631 |
| 148 | CSNK2A2 | 0.42851145 |
| 149 | MAPK4 | 0.41613869 |
| 150 | PAK4 | 0.41504975 |
| 151 | CDK6 | 0.41337372 |
| 152 | SIK2 | 0.41184688 |
| 153 | LRRK2 | 0.41076055 |
| 154 | FGFR3 | 0.40551728 |
| 155 | ATM | 0.40539553 |
| 156 | DYRK2 | 0.39746826 |
| 157 | PKN2 | 0.39727278 |
| 158 | NLK | 0.38022758 |
| 159 | NUAK1 | 0.36915895 |
| 160 | TYK2 | 0.36769730 |
| 161 | CSNK1D | 0.36621441 |
| 162 | BRSK1 | 0.36247950 |
| 163 | GRK1 | 0.36126930 |
| 164 | MOS | 0.35568301 |
| 165 | ERBB2 | 0.33944787 |
| 166 | PRKCI | 0.33594888 |
| 167 | RPS6KB2 | 0.33546193 |
| 168 | ABL2 | 0.33484679 |
| 169 | TYRO3 | 0.33389179 |
| 170 | CSNK2A1 | 0.31449839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.34465450 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.90220460 |
| 3 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.87896294 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.74264441 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.69611012 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.67340343 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56077165 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.52378519 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.42293237 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.33607039 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.30207301 |
| 12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.27634818 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.13836442 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13504641 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12745269 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.07416394 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.03904838 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01196992 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.99060995 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98484164 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.96197374 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.96103232 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95852927 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.94448255 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.91403631 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88534541 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84305111 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.83841494 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80104307 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.79816703 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79796821 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75078032 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.74777933 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73295915 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72680665 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72181053 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.69248337 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.66058225 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65558751 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64770207 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.64341608 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.64140126 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60759388 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.60550930 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59911406 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58568234 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58088242 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.57231399 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57192273 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55993034 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55990668 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.55141857 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.52075368 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.51904060 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.51327600 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.50403584 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48464494 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.48291153 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48169940 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46955511 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46621831 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46275296 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44753583 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42426125 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42290088 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41768558 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.40111412 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.38776519 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37971016 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37963321 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37641906 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36477569 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35611069 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34247162 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32678908 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27155213 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24096836 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23823789 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23385983 |
| 80 | Malaria_Homo sapiens_hsa05144 | 1.20301776 |
| 81 | Asthma_Homo sapiens_hsa05310 | 1.19661717 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18190414 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17769392 |
| 84 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.16839664 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10287541 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 1.09716220 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09157838 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06019588 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05207840 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04495731 |
| 91 | Mismatch repair_Homo sapiens_hsa03430 | 1.03819147 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03631824 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01988060 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 1.01173847 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99598409 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.98006468 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.97134269 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92487259 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89955654 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88550821 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88029105 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87427191 |
| 103 | DNA replication_Homo sapiens_hsa03030 | 0.87041204 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86649719 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86086333 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.83609622 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83450198 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83241391 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81613007 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81077113 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80709962 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80609857 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80554237 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79325807 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.77569242 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76626798 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75643375 |
| 118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75562681 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.74132961 |
| 120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73924700 |
| 121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71528910 |
| 122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70990273 |
| 123 | Protein export_Homo sapiens_hsa03060 | 0.70375132 |
| 124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70181106 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70143592 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69557312 |
| 127 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69496066 |
| 128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69310279 |
| 129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69128357 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.68978020 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68925814 |
| 132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68304067 |
| 133 | RNA transport_Homo sapiens_hsa03013 | 0.67739847 |
| 134 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67737217 |
| 135 | Proteasome_Homo sapiens_hsa03050 | 0.66972043 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66285021 |
| 137 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64440502 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63579311 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.63409817 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62686799 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62569282 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61204401 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60357833 |
| 144 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59693067 |
| 145 | Homologous recombination_Homo sapiens_hsa03440 | 0.59584388 |
| 146 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59166298 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58814626 |
| 148 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58762831 |
| 149 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58688424 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56779611 |
| 151 | Prostate cancer_Homo sapiens_hsa05215 | 0.55950205 |
| 152 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55450744 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.55420355 |
| 154 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54079010 |
| 155 | Mineral absorption_Homo sapiens_hsa04978 | 0.52496498 |
| 156 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52375875 |
| 157 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.50274716 |
| 158 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49859748 |
| 159 | Lysine degradation_Homo sapiens_hsa00310 | 0.49144426 |
| 160 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48857908 |
| 161 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48289557 |
| 162 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47009356 |
| 163 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45971590 |
| 164 | Cell cycle_Homo sapiens_hsa04110 | 0.44627246 |
| 165 | Phagosome_Homo sapiens_hsa04145 | 0.44014852 |
| 166 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43563728 |
| 167 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42812529 |
| 168 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42391185 |
| 169 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42163898 |
| 170 | Base excision repair_Homo sapiens_hsa03410 | 0.40656835 |
| 171 | Spliceosome_Homo sapiens_hsa03040 | 0.40502679 |
| 172 | Shigellosis_Homo sapiens_hsa05131 | 0.40270638 |
| 173 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39648790 |
| 174 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39465721 |
| 175 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37655318 |
| 176 | Ribosome_Homo sapiens_hsa03010 | 0.37466395 |
| 177 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36346259 |
| 178 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35769469 |
| 179 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32975209 |
| 180 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32875166 |
| 181 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32731672 |
| 182 | Purine metabolism_Homo sapiens_hsa00230 | 0.31851649 |

